Even though high immunoreactivity for Plexin-B1 has been reported in a subset of high-grade glioma [28], overall expression of Plexin-B1 or -B3 are not upregulated in gliomas, and their expression levels do not correlate with glioma grade nor patient survival. This evidence concerns the gene PLXNB1 and central nervous system cancer.